Hirshberg Foundation for Pancreatic Cancer Research

Dedicated to advancing pancreatic cancer research and providing support to patients and their families.

Donate
  • ABOUT THE FOUNDATION
    • Agi’s Story
    • About Us →
      • Mission
      • Directors/Trustees
      • Scientific Advisory Board
      • How Our Journey Began
    • News →
      • Latest News
      • Research News
      • Foundation News
      • UCLA Activity Summary Reports
      • Newsletters
      • Press Room
    • Contact
  • PANCREATIC CANCER
    • About the Pancreas →
      • The Pancreas
      • Cancer Cells
      • Risk Factors
      • Symptoms
      • Diagnosis
      • Prognosis
      • Staging
      • Second Opinion
    • Treatment Options →
      • Surgery
      • Chemotherapy
      • Targeted Therapy
      • Radiation Therapy
      • Alternative Treatment Options
      • Clinical Trials
    • Supportive Care →
      • Obstructions
      • Pain Control
      • Nutrition
      • Cannabis
      • Palliative Care
    • Pancreatic Cancer Facts
    • Glossary of Terms
    • Frequently Asked Questions
  • RESEARCH
    • Seed Grant Program →
      • Seed Grant Recipients
      • Frequently Asked Questions
    • Seed Grant News
    • UCLA Program →
      • UCLA Center for Pancreatic Diseases
      • Basic Research
      • Translational Research
      • Sahin-Toth Laboratory
      • UCLA Pancreas Tissue Bank
      • UC Pancreatic Cancer Consortium
      • Simms/Mann Psychosocial →
        • Insights into Cancer
    • American Pancreatic Association
    • NIH Funded Projects
  • PATIENTS & CAREGIVERS
    • Patient Support
    • Where to Begin
    • Caregivers & Families
    • Symposium →
      • Symposium Presentations
    • Patient & Family Webinars
    • Genetic Counseling
    • Resources →
      • NCCN Guidelines for Patients
      • Patient Support Tools
      • Create Your Health Care Team
      • Patient Health Diaries
      • Support Groups
      • Financial Aid
  • HOW YOU CAN HELP
    • Planned Giving
    • Donor-Advised Funds
    • Event Calendar
    • Get Inspired
    • Fundraising Resources
    • November Awareness Month →
      • World Pancreatic Cancer Day
    • More Ways to Give →
      • You Can Help Funds
      • Host Your Own Event
      • Shop Online Store
      • Wedding Program
      • Volunteer
      • Car Program
  • SEARCH
Home / Research / Seed Grant Program / Seed Grant Recipients / Simon Schwörer, Ph.D.

Simon Schwörer, Ph.D.

Simon Schwörer, Ph.D.
Simon Schwörer, Ph.D.
Assistant Professor
Department of Medicine, Hematology/Oncology Division

University of Chicago
Chicago, IL

Elucidating the role of hypoxia in regulating fibroblast heterogeneity in pancreatic cancer

Overview

Aim: Therapy

Pancreatic cancer is the third leading cause of cancer-related deaths in the United States. Currently available therapies to treat PDAC patients provide only limited clinical benefits. One reason for this is the complexity of this disease. Pancreatic cancer is characterized by an aberrant fibro-inflammatory stroma consisting mainly of cancer-associated fibroblasts (CAFs) that are involved in tumor progression and therapy resistance. Many but not all of the fibroblasts in the tumor interact with and help tumor cells to survive and grow. How to selectively target tumor-promoting CAF populations is an important and clinically relevant question but is currently unknown. A better understanding how tumor-promoting fibroblasts are generated in pancreatic cancer will help to develop therapies that can specifically target these cells and leave other normal cells untouched. We hypothesize that the specific metabolic environment in pancreatic tumors that is created by the demands of cancer cells in conjunction with impaired vascular supply can push fibroblasts towards assisting tumor cells. We will test this hypothesis using novel culture and fibroblast reporter systems that we will develop. Specifically, we will determine the role of hypoxia, i.e. oxygen scarcity, in regulating fibroblast heterogeneity, and test the translational relevance of our findings in animal models of pancreatic cancer. Taken together, this study focuses on identifying metabolic factors that drive normal cells in tumors to help cancer cells grow, with the long-term goal to target these factors to improve outcomes of patients.

Patient Support Resources

from the comfort of your home


Our Webinar Library »

Never Give Up.
The journey continues with an end in sight.
Our Stories »
SUBSCRIBE
Our Free E-Newsletter
Sign up to receive information on breaking news, patient programs and upcoming events.
You can custom tailor your subscriptions and unsubscribe at any time.
  • How You Can Help
  • Make A Donation
  • Host an Event
  • Shop Online Store
  • Signature Events
  • L.A. Cancer Challenge
  • Tour De Pier
  • Hirshberg Training Team
  • More
  • News
  • Press
  • Contact

Stay Connected

Join Our E-newsletter

  • Legal and Privacy
  • Financial Information
  • Contact